Jiangsu Nanfang Medical (603880) — Working Capital to Net Assets Ratio
Jiangsu Nanfang Medical (603880) has a Working Capital to Net Assets ratio of -194.9% as of March 2026. Working capital of CN¥-343.42 Million (current assets of CN¥316.71 Million minus current liabilities of CN¥660.14 Million) is measured against net assets of CN¥176.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jiangsu Nanfang Medical leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jiangsu Nanfang Medical Working Capital to Net Assets (2012–2025)
This chart shows how Jiangsu Nanfang Medical's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at -194.9%, reflecting working capital of CN¥-343.42 Million against net assets of CN¥176.20 Million CNY. See 603880 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Jiangsu Nanfang Medical (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu Nanfang Medical from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 603880 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -188.4% | CN¥-341.38 Million | CN¥181.17 Million | CN¥322.00 Million | CN¥663.38 Million | ▼ -68.9 pp |
| 2024 | -119.5% | CN¥-339.98 Million | CN¥284.41 Million | CN¥400.28 Million | CN¥740.26 Million | ▼ -72.6 pp |
| 2023 | -46.9% | CN¥-222.39 Million | CN¥474.22 Million | CN¥569.54 Million | CN¥791.92 Million | ▼ -26.1 pp |
| 2022 | -20.8% | CN¥-129.35 Million | CN¥621.48 Million | CN¥678.35 Million | CN¥807.70 Million | ▼ -24.1 pp |
| 2021 | 3.3% | CN¥21.43 Million | CN¥654.90 Million | CN¥587.89 Million | CN¥566.46 Million | ▼ -37.4 pp |
| 2020 | 40.6% | CN¥284.76 Million | CN¥700.80 Million | CN¥644.24 Million | CN¥359.47 Million | ▲ +3.8 pp |
| 2019 | 36.8% | CN¥208.99 Million | CN¥567.52 Million | CN¥501.45 Million | CN¥292.46 Million | ▼ -23.4 pp |
| 2018 | 60.2% | CN¥337.05 Million | CN¥560.04 Million | CN¥613.08 Million | CN¥276.03 Million | ▲ +2.1 pp |
| 2017 | 58.1% | CN¥312.07 Million | CN¥537.57 Million | CN¥587.38 Million | CN¥275.30 Million | ▲ +26.2 pp |
| 2016 | 31.9% | CN¥81.85 Million | CN¥256.69 Million | CN¥331.53 Million | CN¥249.67 Million | ▼ -4.9 pp |
| 2015 | 36.8% | CN¥81.90 Million | CN¥222.51 Million | CN¥332.04 Million | CN¥250.13 Million | ▼ -11.8 pp |
| 2014 | 48.6% | CN¥102.57 Million | CN¥210.90 Million | CN¥327.85 Million | CN¥225.28 Million | ▲ +11.4 pp |
| 2013 | 37.2% | CN¥62.72 Million | CN¥168.57 Million | CN¥266.63 Million | CN¥203.91 Million | ▲ +8.5 pp |
| 2012 | 28.7% | CN¥34.80 Million | CN¥121.38 Million | CN¥292.21 Million | CN¥257.41 Million | — |